Synphatec
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Synphatec - overview
Established
2021
Location
Shanghai, Shanghai, China
Primary Industry
Biotechnology
About
Based in Shanghai, China and founded in 2021, Synphatec (Shanghai) Biopharmaceutical Technology Co. , Ltd. , trading as Synphatec, focuses on research and development of novel treatments for central nervous system disorders. In September 2026, Synphatec raised over USD 50 million in Series A funding led by Decheng Capital, with participation from Huatai Zijin Investment, China Merchants Venture Investment Management, 5Y Capital, Shunwei Capital and Qianju Capital.
The company focuses on advancing its pipeline of preclinical and early-stage clinical programs targeting psychiatric and neurodegenerative diseases such as depression and Alzheimer's disease. The company's revenue is generated by providing novel treatments for central nervous system disorders. The company will use the funding to advance the clinical development of core pipeline assets SP-101 and SP-201, optimize the i-NaS and SynX technology platforms, and further expand the innovative pipeline to address significant unmet clinical needs.
Current Investors
5Y Capital, Decheng Capital, Shunwei Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Healthcare Specialists, Mental Health Services, Pharmaceutical Research & Development
Website
www.synphatec.com/
Company Stage
Series A
Total Amount Raised
Subscriber access only
Synphatec - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A | Completed | Synphatec | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.